471 related articles for article (PubMed ID: 29914543)
21. Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.
Qin Y; Zhang Y; Tomic I; Hao W; Menger MD; Liu C; Fassbender K; Liu Y
J Alzheimers Dis; 2018; 65(1):243-263. PubMed ID: 30010136
[TBL] [Abstract][Full Text] [Related]
22. The behavioural phenotype of 14-month-old female TAU58/2 transgenic mice.
Kreilaus F; Masanetz R; Watt G; Przybyla M; Ittner A; Ittner L; Karl T
Behav Brain Res; 2021 Jan; 397():112943. PubMed ID: 33017638
[TBL] [Abstract][Full Text] [Related]
23. Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy.
Sun XY; Dong QX; Zhu J; Sun X; Zhang LF; Qiu M; Yu XL; Liu RT
Curr Alzheimer Res; 2019; 16(8):710-722. PubMed ID: 31368873
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model.
Boutajangout A; Quartermain D; Sigurdsson EM
J Neurosci; 2010 Dec; 30(49):16559-66. PubMed ID: 21147995
[TBL] [Abstract][Full Text] [Related]
25. Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD.
Sydow A; Hochgräfe K; Könen S; Cadinu D; Matenia D; Petrova O; Joseph M; Dennissen FJ; Mandelkow EM
Acta Neuropathol Commun; 2016 Feb; 4():17. PubMed ID: 26916334
[TBL] [Abstract][Full Text] [Related]
26. Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice.
Liu W; Zhao L; Blackman B; Parmar M; Wong MY; Woo T; Yu F; Chiuchiolo MJ; Sondhi D; Kaminsky SM; Crystal RG; Paul SM
J Neurosci; 2016 Dec; 36(49):12425-12435. PubMed ID: 27927959
[TBL] [Abstract][Full Text] [Related]
27. Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
Przybyla M; van Eersel J; van Hummel A; van der Hoven J; Sabale M; Harasta A; Müller J; Gajwani M; Prikas E; Mueller T; Stevens CH; Power J; Housley GD; Karl T; Kassiou M; Ke YD; Ittner A; Ittner LM
Brain; 2020 Jun; 143(6):1889-1904. PubMed ID: 32375177
[TBL] [Abstract][Full Text] [Related]
28. Virus-like particle (VLP)-based vaccine targeting tau phosphorylated at Ser396/Ser404 (PHF1) site outperforms phosphorylated S199/S202 (AT8) site in reducing tau pathology and restoring cognitive deficits in the rTg4510 mouse model of tauopathy.
Hulse J; Maphis N; Peabody J; Chackerian B; Bhaskar K
bioRxiv; 2024 Apr; ():. PubMed ID: 38644999
[TBL] [Abstract][Full Text] [Related]
29. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
30. Early behavioural markers of disease in P301S tau transgenic mice.
Scattoni ML; Gasparini L; Alleva E; Goedert M; Calamandrei G; Spillantini MG
Behav Brain Res; 2010 Mar; 208(1):250-7. PubMed ID: 20004218
[TBL] [Abstract][Full Text] [Related]
31. Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology.
Koss DJ; Robinson L; Drever BD; Plucińska K; Stoppelkamp S; Veselcic P; Riedel G; Platt B
Neurobiol Dis; 2016 Jul; 91():105-23. PubMed ID: 26949217
[TBL] [Abstract][Full Text] [Related]
32. Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies.
Dai CL; Chen X; Kazim SF; Liu F; Gong CX; Grundke-Iqbal I; Iqbal K
J Neural Transm (Vienna); 2015 Apr; 122(4):607-17. PubMed ID: 25233799
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease.
Hashem J; Hu M; Zhang J; Gao F; Chen C
Mol Neurobiol; 2021 Aug; 58(8):4122-4133. PubMed ID: 33939165
[TBL] [Abstract][Full Text] [Related]
34. Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice.
Kreilaus F; Przybyla M; Ittner L; Karl T
Behav Brain Res; 2022 May; 425():113812. PubMed ID: 35202719
[TBL] [Abstract][Full Text] [Related]
35. Blocking Site-Specific Cleavage of Human Tau Delays Progression of Disease-Related Phenotypes in Genetically Matched Tau-Transgenic Mice Modeling Frontotemporal Dementia.
Steuer EL; Kemper LJ; Hlynialuk CJW; Leinonen-Wright K; Montonye ML; Lapcinski IP; Forster CL; Ashe KH; Liu P
J Neurosci; 2022 Jun; 42(23):4737-4754. PubMed ID: 35508385
[TBL] [Abstract][Full Text] [Related]
36. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
37. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
38. Early Aβ-HBc virus-like particles immunization had better effects on preventing the deficit of learning and memory abilities and reducing cerebral Aβ load in PDAPP mice.
Feng G; Zheng C; Hui J
Vaccine; 2018 Aug; 36(35):5258-5264. PubMed ID: 30055971
[TBL] [Abstract][Full Text] [Related]
39. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice.
Yao Y; Chang Y; Li S; Zhu J; Wu Y; Jiang X; Li L; Liu R; Ma R; Li G
Brain Res Bull; 2023 Aug; 200():110685. PubMed ID: 37330021
[TBL] [Abstract][Full Text] [Related]
40. Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
Hou TY; Zhou Y; Zhu LS; Wang X; Pang P; Wang DQ; Liuyang ZY; Man H; Lu Y; Zhu LQ; Liu D
J Neurochem; 2020 Aug; 154(4):441-457. PubMed ID: 31951013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]